Doctor Michael Lehrke
RWTH University Hospital Aachen, Aachen (Germany)
Panel discussion.
Event: ESC Congress 2020
Topic: Pharmacotherapy
Session: Discussing clinical implications of glucagon-like peptide-1 receptor agonists
Evaluating cardiovascular risk reduction with glucagon-like peptide-1 receptor agonists.
Event: ESC Congress 2020
Topic: Pharmacotherapy
Session: Discussing clinical implications of glucagon-like peptide-1 receptor agonists
GLP-1 levels predict cardiovascular risk in patients with acute myocardial infarction
Event: ESC Congress 2019
Topic: Biomarkers
Session: Acute Coronary Syndromes: Biomarkers
ESC 365 is supported by
